A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007136:Immunoglobulins; D008175:Lung Neoplasms / Q000473:pathology*; D014529:Uridine / Q000378:metabolism; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014751:Vindesine
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D007136:Immunoglobulins; D014747:Vinblastine; D014751:Vindesine; D014529:Uridine